Dongbei Pharmaceutical Group

Dongbei Pharmaceutical Group is a leading Chinese pharmaceutical manufacturer headquartered in Shenyang, specializing in the production of active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 1946, the company is one of the oldest and largest pharmaceutical bases in China, renowned globally as a major supplier of Vitamin C, caffeine, and various antibiotics. Its extensive portfolio covers multiple therapeutic areas, including anti-infectives, cardiovascular health, and neurology, with products exported to over 100 countries. Following a significant ownership reform in 2018, the company is now part of the Fangda Group, which has driven modernization and expansion of its manufacturing capabilities. Dongbei Pharma is listed on the Shenzhen Stock Exchange and continues to be a critical player in the global healthcare supply chain.